122 related articles for article (PubMed ID: 8481363)
1. Assessment of visual function for patients on tamoxifen.
Duchesne GM
Clin Oncol (R Coll Radiol); 1993; 5(2):128. PubMed ID: 8481363
[No Abstract] [Full Text] [Related]
2. Long-term tamoxifen citrate use and potential ocular toxicity.
Gorin MB; Day R; Costantino JP; Fisher B; Redmond CK; Wickerham L; Gomolin JE; Margolese RG; Mathen MK; Bowman DM; Kaufman DI; Dimitrov NV; Singerman LJ; Bornstein R; Wolmark N
Am J Ophthalmol; 1998 Apr; 125(4):493-501. PubMed ID: 9559735
[TBL] [Abstract][Full Text] [Related]
3. Ocular toxicity of tamoxifen.
Gerner EW
Ann Ophthalmol; 1989 Nov; 21(11):420-3. PubMed ID: 2619152
[TBL] [Abstract][Full Text] [Related]
4. Crystalline maculopathy: a rare complication of tamoxifen therapy.
Srikantia N; Mukesh S; Krishnaswamy M
J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
[TBL] [Abstract][Full Text] [Related]
5. Ocular assessment of patients treated with tamoxifen.
Beck M; Mills PV
Cancer Treat Rep; 1979; 63(11-12):1833-4. PubMed ID: 526917
[TBL] [Abstract][Full Text] [Related]
6. Should we discontinue tamoxifen in a patient with vision-threatening ocular toxicity related to low-dose tamoxifen therapy?
Tsai DC; Chen SJ; Chiou SH; Lee AF; Lee FL; Hsu WM
Eye (Lond); 2003 Mar; 17(2):276-8. PubMed ID: 12640432
[No Abstract] [Full Text] [Related]
7. Reversible ocular toxicity related to tamoxifen therapy.
Ashford AR; Donev I; Tiwari RP; Garrett TJ
Cancer; 1988 Jan; 61(1):33-5. PubMed ID: 3334951
[TBL] [Abstract][Full Text] [Related]
8. A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma.
Longstaff S; Sigurdsson H; O'Keeffe M; Ogston S; Preece P
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1805-8. PubMed ID: 2632262
[TBL] [Abstract][Full Text] [Related]
9. Branch retinal vein occlusion associated with tamoxifen use.
Onder Hİ; Kilic AC; Kose SA; Karatas A; Kaya E; Kaya M; Tunc M
Semin Ophthalmol; 2013 Mar; 28(2):88-90. PubMed ID: 23448563
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-induced ocular toxicity.
Mihm LM; Barton TL
Ann Pharmacother; 1994 Jun; 28(6):740-2. PubMed ID: 7919565
[No Abstract] [Full Text] [Related]
11. Retinal changes associated with tamoxifen treatment for breast cancer.
Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
[TBL] [Abstract][Full Text] [Related]
12. [Ophthalmologic complications of low-dosage tamoxifen in the treatment of breast carcinoma].
de Jong-Busnac M
Ned Tijdschr Geneeskd; 1989 Mar; 133(10):514-6. PubMed ID: 2710233
[TBL] [Abstract][Full Text] [Related]
13. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.
Heier JS; Dragoo RA; Enzenauer RW; Waterhouse WJ
Am J Ophthalmol; 1994 Jun; 117(6):772-5. PubMed ID: 7880223
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen retinopathy.
Kaiser-Kupfer MI; Lippman ME
Cancer Treat Rep; 1978 Mar; 62(3):315-20. PubMed ID: 647693
[TBL] [Abstract][Full Text] [Related]
15. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
[TBL] [Abstract][Full Text] [Related]
16. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
Salomão SR; Watanabe SE; Berezovsky A; Motono M
Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen and ocular toxicity.
Ah-Song R; Sasco AJ
Cancer Detect Prev; 1997; 21(6):522-31. PubMed ID: 9398992
[TBL] [Abstract][Full Text] [Related]
18. Ocular findings in breast cancer patients using tamoxifen.
Ugurlu S; Karagoz A; Altin Ekin M
Cutan Ocul Toxicol; 2015 Mar; 34(1):16-20. PubMed ID: 24678744
[TBL] [Abstract][Full Text] [Related]
19. Long-term toxicity of tamoxifen.
Rutqvist LE
Recent Results Cancer Res; 1993; 127():257-66. PubMed ID: 8502824
[TBL] [Abstract][Full Text] [Related]
20. To stop or not? Tamoxifen therapy for secondary prevention of breast cancer in a patient with ocular toxicity.
Bommireddy T; Carrim ZI
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
